ShareValue scores for AHE.AU: Valuation 67, Quality 46, Growth 44, Health 56.
AHE.AUASX
Adheris Health Limited
A$0.02
(0.00%)
AHE.AUASX
Adheris Health Limited
A$0.02(0.00%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
7% to 17%
Rating
Trap Risk
Return
7% to 17%
Valuation
67
Fair Value
Price vs Value
Quality
46
Moderate
Business Strength
Growth
44
Moderate
Revenue & Earnings
Health
56
Moderate
Financial Stability
Momentum
41
Neutral
Price Trend
Company Details
About
Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, the United States, and the United Kingdom. The company offers THRiV, an omni-channel platform which provides pharmacy-driven patient and pharmacist engagement solutions to improve medication management. The company was formerly known as MedAdvisor Limited and changed its anme to Adheris Health Limited in November 2025. The company was incorporated in 2010 and is based in Woburn, Massachusetts.
Market Cap$11M
P/E RatioN/A
Dividend YieldNone
Sector Rank#1101
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026